Head and Neck Cancer

Hemoglobin Levels Can Help Predict Chemoradiation Therapy Outcome

Published in Cancer Weekly, December 12th, 2000

Hemoglobin levels prior to chemoradiation therapy for advanced head and neck cancer provide an accurate prognostic marker of outcome, suggesting a possible adjunct therapy, researchers in Germany report.

"The pretherapeutic hemoglobin level...has been postulated to constitute a prognostic marker for outcome after primary chemoradiation of patients with advanced cancer of the head and neck," wrote Andreas Dietz and colleagues at the University of Heidelberg in the journal HNO. "However, this hypothesis has not been tested systematically in large study samples."

Dietz et al., therefore, reviewed data from two large multicenter trials involving...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-12-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry